As reported for isatuximab and daratumumab, mass spectrometry analyses and the use of specific IFE-reflex assays (i.e., isatuximab Hydrashift assay, DIRA assay) can overcome interference by these therapeutic antibodies and allow more accurate measurements of serum M-protein in MM patients [48, 53,54,55]
While genetics don't affect storage requirements, understanding your peptide pathway sensitivity helps PlexusDx optimize your starting dose and titration schedule, making proper storage even more critical to achieving consistent, personalized results
doi: 10.1002/advs.202409837
In general, if you have a diagnosed B12 deficiency or are undergoing treatment for low B12, your healthcare provider may schedule follow-up tests to monitor your progress and ensure that B12 levels are within a healthy range
of this final rule with comment period for program-specific background information, including the statutory authorities and previously finalized and newly proposed measure sets, for the Hospital Outpatient Quality Reporting (OQR), Rural Emergency Hospital Quality Reporting (REHQR), and Ambulatory Surgical Center Quality Reporting (ASCQR) Programs, respectively